MedPath

A Post marketing study to see safety and efficacy of combination of Amitriptyline and Chlordiazepoxide in management of depression with co-morbid anxiety

Not Applicable
Recruiting
Conditions
Anxiety disorder, unspecified,
Registration Number
CTRI/2021/03/031971
Lead Sponsor
Dr Reddys Laboratories Ltd
Brief Summary

This multicentric single arm post marketing surveillance study would be performed in patients of anxiety comorbid with depression, who have been newly prescribed FDC of Amitriptyline and Chlordiazepoxide tablets of Dr. Reddy’s Laboratories Ltd. All the enrolled patients will be followed up for 60 day and will be assessed for HAM-A and HAM-D assessment. Patients will be encouraged to report adverse events throughout the study period. All the data generated will be analysed using appropriate statistical test.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
375
Inclusion Criteria

Patient with anxiety comorbid with depression Newly Prescribed with Libotryp or Libotryp DS as per clinical discretion of investigator.

Exclusion Criteria

Patients who is not able to understand the nature of study and willing to provide written informed consent.

Study & Design

Study Type
PMS
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To actively surveil safety of FDC of Amitriptyline and Chlordiazepoxide tablets in management of depression with co-morbid anxiety in India in terms of Sedative effects and Anticholinergic side effects and Dizziness and Decrease in LibidoIncidence of any of the following event | Sedative effects or Anticholinergic side effects | or Dizziness or Decrease in Libido or AE or SAE at Day 30 and Day 60 after study using study medication
Secondary Outcome Measures
NameTimeMethod
To passively evaluate Safety reports such as adverse drug reactions, laboratory parameters, ECG (if available)To evaluate Efficacy as change in Hamilton Anxiety Score (HAM-A) and Hamilton Depression Score (HAM-D) score

Trial Locations

Locations (6)

Chopda Medicare and Research Centre Pvt limited Magnum Heart institute

🇮🇳

Nashik, MAHARASHTRA, India

Dr D Y Patil Medical College hospital and research centre

🇮🇳

Pune, MAHARASHTRA, India

K.S. Hegde Medical Academy

🇮🇳

Kannada, KARNATAKA, India

Life Care Clinic

🇮🇳

Salem, TAMIL NADU, India

Lokmanya Tilak Muncipal Medical college and general hospital

🇮🇳

Mumbai, MAHARASHTRA, India

Sahyadri Super specialty hospital

🇮🇳

Pune, MAHARASHTRA, India

Chopda Medicare and Research Centre Pvt limited Magnum Heart institute
🇮🇳Nashik, MAHARASHTRA, India
Umesh Nagapurkar
Principal investigator
9823146088
umeshanjali@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.